Is corona virus infection a risk factor for hematuria in secondary bladder amyloidosis? The first case report.

Djafari, Anahita Ansari; Hasanzadeh, Katayoun; Masrour, Homa; Ahadi, Mahsa; Dargahi, Majid; Rahavian, Amirhossein

Djafari, Anahita Ansari; Hasanzadeh, Katayoun; Masrour, Homa; Ahadi, Mahsa; Dargahi, Majid; Rahavian, Amirhossein.

Djafari AA; Urology, Department of Urology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hasanzadeh K; Internal Medicine Ward, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Masrour H; Internal Medicine Ward, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ahadi M; Department of Pathology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Dargahi M; Urology, Department of Urology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Rahavian A; Andrology Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Urol Case Rep ; 38: 101642, 2021 Sep.

Article in English | MEDLINE | ID: covidwho-1141764

ABSTRACT

ABSTRACT

Urogenital amyloidosis is a rare disease that involved every site of the urogenital system. Involvement of bladder developed with gross hematuria, and any intrinsic or extrinsic stresses exacerbate hematuria. We reported a secondary bladder amyloidosis case that presented with gross hematuria without any risk factor except COVID-19 infection.

Keywords

Amyloidosis; Bladder; COVID-19; Case report; Hematuria

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Language: English Journal: Urol Case Rep Year: 2021 Document Type: Article Affiliation country: J.eucr.2021.101642

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google